BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Babic Z, Svoboda-Beusan I, Kucisec-Tepes N, Dekaris D, Troskot R. Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection. World J Gastroenterol 2005; 11(18): 2720-2725 [PMID: 15884110 DOI: 10.3748/wjg.v11.i18.2720]
URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2720.htm
Number Citing Articles
1
Inga Dietz, Stefan Jerchel, Márta Szaszák, Kensuke Shima, Jan Rupp. When oxygen runs short: the microenvironment drives host–pathogen interactionsMicrobes and Infection 2012; 14(4): 311 doi: 10.1016/j.micinf.2011.11.003
2
Marhanis OMAR, Andrew CROWE, Richard PARSONS, Hooi EE, Chin Yen TAY, Jeffery HUGHES. P-glycoprotein expression in Helicobacter pylori-positive patients: The influence of MDR1 C3435T polymorphismJournal of Digestive Diseases 2012; 13(8): 414 doi: 10.1111/j.1751-2980.2012.00606.x
3
Mei Zhang. High antibiotic resistance rate: A difficult issue for <i>Helicobacter pylori</i> eradication treatmentWorld Journal of Gastroenterology 2015; 21(48): 13432-13437 doi: 10.3748/wjg.v21.i48.13432
4
Noor Safwah Damanhuri, Endang Kumolosasi, Marhanis Salihah Omar, Amirul Faiz Abd Razak, Ahmad Hasnan Mansor. The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley ratsDARU Journal of Pharmaceutical Sciences 2021; 29(1): 13 doi: 10.1007/s40199-020-00377-2
5
Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Chise Kodaira, Masafumi Nishino, Mihoko Yamade, Mutsuhiro Ikuma, Haruhiko Sugimura, Takashi Ishizaki, Akira Hishida. MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in JapaneseLife Sciences 2008; 83(7-8): 301 doi: 10.1016/j.lfs.2008.06.022
6
Marhanis Omar, Andrew Crowe, Chin Yen Tay, Jeffery Hughes. Expressions of P-glycoprotein in treatment - Resistant Helicobacter pylori patientsJournal of Applied Biomedicine 2014; 12(4): 263 doi: 10.1016/j.jab.2014.02.001
7
Susan M. Abdel-Rahman, Gordon L. Amidon, Ajay Kaul, Viera Lukacova, Alexander A. Vinks, Gregory T. Knipp. Summary of the National Institute of Child Health and Human Development–Best Pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop–Pediatric Biopharmaceutics Classification System Working GroupClinical Therapeutics 2012; 34(11): S11 doi: 10.1016/j.clinthera.2012.09.014
8
Brandon J. Kim, Maura A. McDonagh, Liwen Deng, Benjamin D. Gastfriend, Alexandra Schubert-Unkmeir, Kelly S. Doran, Eric V. Shusta. Streptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cellsFluids and Barriers of the CNS 2019; 16(1) doi: 10.1186/s12987-019-0146-5